Improving Cancer Care for Women Seeking Services in the Veterans Health Administration Through the Breast and Gynecological Oncology System of Excellence.


Journal

Military medicine
ISSN: 1930-613X
Titre abrégé: Mil Med
Pays: England
ID NLM: 2984771R

Informations de publication

Date de publication:
23 Sep 2024
Historique:
received: 20 06 2024
revised: 15 08 2024
accepted: 06 09 2024
medline: 23 9 2024
pubmed: 23 9 2024
entrez: 23 9 2024
Statut: aheadofprint

Résumé

Women are the fastest growing population among Veterans and have substantial risk factors that increase their likelihood for developing cancer. To ensure that the Department of Veterans Affairs Veterans Health Administration (VHA) offers the best possible cancer care to women Veterans, it established the Breast and Gynecologic Oncology System of Excellence (BGSoE) in 2021. The BGSoE offers telehealth oncology services and a comprehensive cancer navigation program. Veterans are identified through physician referral or through the BGSoE dashboard which integrates ICD-10 codes and text mining from VA electronic health records to identify eligible Veterans with breast or gynecological cancers. Descriptive statistics, including Veteran demographics and geographical location, were derived from BGSoE dashboard data. From January 1, 2021 to March 15, 2024, the BGSoE identified a total of 7,187 incident cases of breast or gynecological cancer among living Veterans. Most cancers were breast (78%) versus gynecological cancers (22%) and 10% of Veterans with breast cancer were identified as male. The average age at diagnosis was 59 for Veterans with breast cancer and 56 for those Veterans with gynecological cancers. Among Veterans in the BGSoE, 28% identified as Black and 6% identified as Hispanic. As the prevalence of women Veterans requiring cancer-related care continues to rise, it will be essential for VHA to evaluate the equitable reach, quality, and acceptability of women-focused cancer health services. The BGSoE focuses on providing high-quality and coordinated clinical cancer care. Veterans Health Administration also established the Center for Oncology Outcomes Review and Gender (COURAGE) to evaluate the BGSoE and continue to strengthen cancer care services in VHA. Initial evaluation objectives include establishing an evidence base regarding Veterans with breast and gynecological cancers, including their experiences with cancer care in the VHA. Eventually, COURAGE will provide ongoing monitoring and evaluation to continue to grow and improve cancer care in the VHA.

Identifiants

pubmed: 39312402
pii: 7766052
doi: 10.1093/milmed/usae447
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Published by Oxford University Press on behalf of the Association of Military Surgeons of the United States 2024. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Auteurs

Megan Shepherd-Banigan (M)

Center of Innovation to Accelerate Discovery and Practice Transformation, Durham VA Health Care System, Durham, NC 27705, USA.
Department of Population Health Sciences, Duke University School of Medicine, Durham, NC 27701, USA.
Mid-Atlantic MIRECC, Durham VA Health Care System, Durham, NC 27705, USA.
Duke-Margolis Health Policy Institute, Duke University, Durham, NC 27708, USA.

Leah L Zullig (LL)

Center of Innovation to Accelerate Discovery and Practice Transformation, Durham VA Health Care System, Durham, NC 27705, USA.
Department of Population Health Sciences, Duke University School of Medicine, Durham, NC 27701, USA.

Theodore S Z Berkowitz (TSZ)

Center of Innovation to Accelerate Discovery and Practice Transformation, Durham VA Health Care System, Durham, NC 27705, USA.

Graham Cummin (G)

Center of Innovation to Accelerate Discovery and Practice Transformation, Durham VA Health Care System, Durham, NC 27705, USA.

Karen M Goldstein (KM)

Center of Innovation to Accelerate Discovery and Practice Transformation, Durham VA Health Care System, Durham, NC 27705, USA.
Division of General Internal Medicine, Duke, Duke University School of Medicine, Durham, NC 27701, USA.

Michael J Kelley (MJ)

Department of Veterans Affairs, National Oncology Program, Washington, DC 27705, USA.
Hematology-Oncology, Durham Veterans Affairs Health Care System, Durham, NC 27701, USA.
Duke Cancer Institute, Durham, NC 27701, USA.

Neetu Chawla (N)

VA Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA.

Hollis J Weidenbacher (HJ)

Center of Innovation to Accelerate Discovery and Practice Transformation, Durham VA Health Care System, Durham, NC 27705, USA.

Aditi Hazra (A)

Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Massachusetts Veterans Epidemiology Research and Information Center, VA Boston Healthcare System, Boston, MA 02130, USA.

Ahmad S Halwani (AS)

Department of Veterans Affairs, National Oncology Program, Washington, DC 27705, USA.
George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT 84148, USA.
University of Utah School of Medicine, Salt Lake City, UT 84113, USA.
Huntsman Cancer Institute, Salt Lake City, UT 84112, USA.

Vikas Patil (V)

George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT 84148, USA.
University of Utah School of Medicine, Salt Lake City, UT 84113, USA.

Kelli M Rasmussen (KM)

George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT 84148, USA.
University of Utah School of Medicine, Salt Lake City, UT 84113, USA.

Rachel Pace (R)

Center of Innovation to Accelerate Discovery and Practice Transformation, Durham VA Health Care System, Durham, NC 27705, USA.

Sarah Colonna (S)

Department of Veterans Affairs, National Oncology Program, Washington, DC 27705, USA.
George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT 84148, USA.
University of Utah School of Medicine, Salt Lake City, UT 84113, USA.
Huntsman Cancer Institute, Salt Lake City, UT 84112, USA.

Haley Moss (H)

Hematology-Oncology, Durham Veterans Affairs Health Care System, Durham, NC 27701, USA.
Duke Cancer Institute, Durham, NC 27701, USA.

Classifications MeSH